NETWORK18 MEDIA: Q1 CONS NET PROFIT 95.7M RUPEES VS LOSS 622M (YOY); PROFIT 391M (QOQ) || Q1 REVENUE 12.14B RUPEES VS 8.07B (YOY); 14.15B (QOQ)

JSW ISPAT SPECIAL PRODUCTS: Q1 CONS NET PROFIT 644M RUPEES VS LOSS 1.55B (YOY) | PROFIT 943.3M (QOQ) || Q1 REVENUE 14.6B RUPEES VS 5.95B (YOY)

KOHINOOR FOODS Q1 : Net Profit Up 35 % To Rs 7.7 cr (QOQ), RS 68 CR loss YOY

Revenue Up 56 % to Rs 81.6 cr (QOQ), Up 13 % YOY

Glenmark Life Sciences Ltd IPO Details

Issue Dates: 27th to 29th July 2021
Fresh Issue: ₹ 1060 Crs
+ OFS: 63,00,000 Shares
Issue Size: ₹ 1515 Crs. (Approx.)
Issue Prize: ₹ 720 to ₹ 725 (Tentative)
Lot Size: 20 Shares (Tentative)
Retail Quota: 35%
Face Value: ₹ 2/- per Share

Basis of Allotment: August 3, 2021
Initiation of Refunds: August 4, 2021
Credit of Shares: August 5, 2021
IPO Listing Date: August 6, 2021


#IPO

Jubilant Ingrevia: Strong

♻️ Rev up 55% YoY, 25% EBITDA margin, Pat up 220%
♻️ speciality chemicals up 18%, nutrition business up 13%, life sciences up 103% | favourable market and raw material conditions
♻️ FY 22 Capex at 350Cr
♻️ reduced debt by 45Cr

#Q1withJST #Pharma https://t.co/yISBEVANf1

Securities in Ban For Trade Date 22-July-2021:

CADILLHC
CANBANK
IBULHSGFIN
NATIONALALUM
NMDC
SUNTV


*Added - CANBANK*
*Deleted-PNB,SAIL*

*MNCL | Jubilant Ingrevia | When Specialty meets value*

MCap: INR 9350crs
CMP: INR 587
Base Case TP: INR 770
Upside: 31%

_*First Cut: Extremely encouraging performance on the back of Acetyls and Specialty Segment*_

_*Ingrevia trades at ~11.4x FY23E EV/EBITDA. Given that Specialty and Nutrition business contributes >70% of our FY23E EBITDA, we believe there is room for further re-rating*_

• *Financial Performance*
- Sales at INR 1145crs up 6% QoQ / 55% YoY
- EBITDA at INR 287crs up 43% QoQ / 126% YoY
- EBITDA margins 25% vs 19% QoQ
- Inventory gains of INR ~63crs; adjusting which EBITDA margins at 20%
- PAT at INR 168crs vs INR 96crs QoQ

• *Life Science Chemicals*: Operating at 27% EBITDA margins. Of the INR 187crs EBITDA for the segment, INR 60crs of which is led by Inventory gains on account of Acetic Acid. The demand scenario continues to remain strong; pricing however as per us should moderate over the medium term.

• *Specialty*: 18% Top-line growth and 22% bottom-line growth. Largely led by volumes in pyridines, we believe this is backed by Chinese ADD being taken off. Performance in this segment as per us is likely to continue. Diketene commercial production to be live in Q3FY22; strategy is target import substitution.

• *Nutrition*: EBITDA de-grew on account of higher input cost and MEIS incentives taken off. Strong demand across customers and margins are likely to improve on account of pass-on of higher input costs.

• *New Areas*: As guided earlier, Capex during the year is expected to be INR 350crs. New CDMO unit and 2 new multi-purpose plants for Specialty Chemicals to commercialize in Q1FY23; this should further improve EBITDA share of Specialty Chemicals.

• We have a base case March-22 target price of *INR 770* valuing at 15x EV/EBITDA, which implies 31% upside on the CMP. Our *Bull / Bear case TP is at INR 1015 and INR 450* respectively.

CRISIL:
Q1 CONS NET PROFIT 1.01B RUPEES VS 663.4M (YOY);EST 840M | 835M (QOQ)

Q1 REVENUE 5.29B RUPEES VS 4.72B (YOY); 4.95B(QOQ)

CO APPROVED PAYMENT OF INTERIM DIVIDEND OF 8 RUPEES PER SHARE

Bajaj Finance Q1 – First Cut …NII ahead of expectation…. Net profit below expectation on account of higher provision

·   Net profit Rs1000cr (up 4% YoY) – expectation Rs1373cr

·   GNPA 2.96% vs 1.4%

·   Provision Rs1750cr (up 4% YoY) – expectation Rs1500cr

·   Interest Income Rs4490cr – expectation Rs3910cr

Maruti Suzuki to launch EVs by 2025; India to be first country to see new electric car via @BT_India https://www.businesstoday.in/auto/story/maruti-suzuki-to-launch-evs-by-2025-india-to-be-first-country-to-see-new-electric-car-301874-2021-07-20?utm_source=btweb_story_share

#TOP10 #StocksInFocus
1- HCL TECH / MASTEK
2- ACC
3- HDFC LIFE
4- BAJAJ FINANCE
5- ASIAN PAINTS
6- ADANI GROUP
7- INDIAN BANK / NIPPON LIFE AMC
8- ZEN TECH
9- ICICI PRU LIFE
10- ICICI SEC / JUBILANT INGREVIA

Today's Infographic: *The Unicorns of 2021*

🌐 Browser Stack - $4 Bn
👨‍🍳 Digit Insurance - $3.5 Bn
💳 Cred - $2.2 Bn
👥 Share Chat - $2.1 Bn
💊 Pharm Easy - $1.5 Bn
🏀🏀🏀🏀🏀🍎🍎🍎🍎

ITC Group FY21 foreign exchange earning rises 29% to Rs 5,934 cr | freepressjournal - https://www.freepressjournal.in/business/itc-group-fy21-foreign-exchange-earning-rises-29-to-rs-5934-cr

JK LAKSHMI CEMENT: MUTUAL FUNDS INCREASED ITS STAKE 2.15% IN CO DURING Q1 || INDIA CAPITAL FUND LID REDUCE ITS STAKE 0.30% IN CO DURING Q1 AND GOVERNMENT PENSION FUND GLOBAL REDUCE ITS STAKE 0.30% IN CO DURING Q1, ARJUNA FUND PTE.LTD SOLD ITS ALL STAKE 1.01% IN CO DURING Q1 || HDFC LIFE INSURANCE COMPANY LIMITED
REDUCE ITS STAKE 0.60% IN CO DURING Q1

GE POWER INDIA :ADITYA BIRLA SUN LIFE INSURANCE COMPANY LIMITED REDUCE ITS STAKE 1% IN CO DURING Q1

VEDANTA :SOCIETE GENERALE SOLD ITS Entire STAKE 1.04% IN CO DURING Q1

5PAISA CAPITAL: ANIRUDDHA DANGE AND VASUDEV JAGANNATH NUGGEHALLI SOLD ITS ALL STAKE 1.12% AND 1.10% IN CO DURING Q1

JSW ENERGY: AQUARIUS INDIA OPPORTUNITIES FUND INCREASED ITS STAKE 0.50% IN CO DURING Q1 || LIC INSREASED 0.60% IN CO DURING Q1

CCL PRODUCTS: MUTUAL FUNDS INCREASED ITS STAKE 2.66% IN CO DURING Q1 || MALABAR INDIA FUND LIMITED SOLD ITS ALL STAKE 1.43% ION CO DURING Q1